Invest now

Tata India Pharma & Healthcare Fund Regular Growth

  • Sector - Healthcare
  • Equity
  • Very High Risk

Rating:

Rating Star

Key Metrics

Aum

₹1,511.49 Cr

Expense Ratio

2.37%

Exit Load

0.25%

Min. Investment

₹5,000.00

Min. SIP

₹100.00

Launch Date

28 Dec 2015

CAGR Returns

Invest on
PeriodAbsolute(%)Annualised(%)
1 Month+2.6%--
3 Months-3.55%--
6 Months+6.69%--
1 Year+5.22%+5.22%
2 Years--+3.24%
3 Years+63.95%+17.92%
5 Years+88.65%+13.54%
Since Launch+226.61%+11.52%

Holdings as on 8 Nov 2026

NameValue (₹Cr)Holding %
Sun Pharmaceutical Industries
120.847.99
Abbott India
89.755.94
HealthCare Global Enterprises Ltd
89.525.92
Divi's Laboratories
85.825.68
Dr Reddy's Laboratories
70.324.65
Apollo Hospitals Enterprise
65.914.36
Rainbow Children's Medicare
65.074.30
Cipla
63.794.22
Torrent Pharmaceuticals
56.893.76
Max Healthcare Institute
56.103.71

Morning Star Rating

Rating:

Rating Star

Risk

Medium

Return

High

Risk & Volitility

0.65

Sharpe Ratio

16.71%

Std. Deviation

10.07%

Tracking Error

11.23%

Alpha

0.70

Beta

Peer Comparison

Fund Name1Y3Y5Y
UTI Healthcare Fund Regular Plan Growth+16.17%+23.25%+15.72%
Mirae Asset Healthcare Fund Regular Growth+20.29%+22.85%+15.33%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth+15.64%+20.01%+13.75%
Tata India Pharma & Healthcare Fund Regular Growth+5.22%+17.92%+13.54%
HDFC Pharma and Healthcare Fund Regular Growth+24.81%+29.79%--

Results are calculated on CAGR basis

About Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

The Tata India Pharma & Healthcare Fund Regular Growth has an AUM of 1511.49 crores & has delivered CAGR of 13.54 in the last 5 years. The fund has an exit load of 0.25% and an expense ratio of 2.37%. The minimum investment in Tata India Pharma & Healthcare Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 100.

As per morningstar the risk & return rating of the fund are Medium & High respectively.

The fund has a present cash holding of %. The top holdings of the fund include Sun Pharmaceutical Industries, Abbott India, HealthCare Global Enterprises Ltd, Divi's Laboratories.

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Chemical Manufacturing, Major Drugs.

Some of the similar funds are UTI Healthcare Fund Regular Plan Growth, Mirae Asset Healthcare Fund Regular Growth, Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, Tata India Pharma & Healthcare Fund Regular Growth, HDFC Pharma and Healthcare Fund Regular Growth. Tata India Pharma & Healthcare Fund Regular Growth has a sharpe ratio of 0.65 & a standard deviation of 16.71%.

FAQs

According to the morning star rating Tata India Pharma & Healthcare Fund Regular Growth has a Medium risk & High return.

Tata India Pharma & Healthcare Fund Regular Growth is managed by Rajat Srivastava.

The expense ratio of Tata India Pharma & Healthcare Fund Regular Growth is 2.37%.

The 5 year annualized return on Tata India Pharma & Healthcare Fund Regular Growth is 13.54% & it has generated 5.22% in the last 1 year.

The minimum investment in Tata India Pharma & Healthcare Fund Regular Growth is 5000 Rs.

Tata India Pharma & Healthcare Fund Regular Growth has an AUM of 1511.49 crores.